How HB 477 changes current law

AI-generated reading aid from the bill's amendatory text — verify against the official bill.

The bill revises the definition of 'drug paraphernalia' to exclude certain narcotic-drug-testing products from being classified as such.

• Section 893.145

  excluding narcotic-drug-testing products that are used solely to determine whether a controlled substance contains fentanyl as described in s. 893.03(2)(b)9., dangerous fentanyl or fentanyl analogues as or any other controlled substance specified in s. 893.135(1)(c)4.a., or xylazine as described in s. 893.03(1)(c)37. → excluding narcotic-drug-testing products that are used solely to determine whether a controlled substance contains fentanyl as described in s. 893.03(2)(b)9., dangerous fentanyl or fentanyl analogues, or any other controlled substance specified in s. 893.135(1)(c)4.a., or xylazine as described in s. 893.03(1)(c)37.

  This change clarifies that certain narcotic-drug-testing products used for identifying fentanyl and similar substances are not considered drug paraphernalia.